Publications Office of the EU
Isolation and concentration of staphylococcal anatoxins from culture solutions. Standardization of developed procedures. - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates CPV codes deduced from the text of the procedure

- indicates text translated automatically in your browsing language

Isolation and concentration of staphylococcal anatoxins from culture solutions. Standardization of developed procedures. Text automatically translated in your browsing language Automatically translated

  • Published
    22/05/2025
  • Today
    20/06/2025
  • Deadline
    22/06/2025
Status
Published
Type of contract
Services
Subject for Renewal
No
Buyer
AUMED, a.s.
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: CZ010 Hlavní město Praha
Business sector (Main CPV)
73100000 Research and experimental development services
Total estimated contract value (excluding VAT)
6,000,000.00 CZK
Total final contract value (excluding VAT)
Not available
Tender reference number
Not available
Description

The subject of the contract is the isolation and concentration of staphylococcal anatoxins from culture solutions together with standardization of developed procedures. As part of the service, the procuring entity requires the following sub-activities: The sponsor shall supply culture media containing anatoxins obtained as haemolysins during the cultivation of the above-mentioned vaccine bacterial staphylococcal strains. Specifically, the contract concerns inactivated haemolysine alfa, beta and, if present in the medium, delta. We require the development of technology for the isolation and purification of these anatoxins from the supplied culture media that contain them. The developed technology will be standardized and will be usable in any commercial production at the level of GMP requirements. (b) The service will also include the development of technology for concentrating isolated and purified, above mentioned, anatoxins. The technology of the anatoxin concentration process will be standardized and will be applicable in any commercial production at the level of GMP requirements. (c) The output of the service will be documentation for points (a), (b) and the design of methodologies for control tests applicable to quality control of these semi-finished products in production. Another output of the service will be the delivery of samples of concentrated anatoxins obtained under points (a), (b). For each anatoxin, 10 ml of concentrate with documentation will be supplied. Text automatically translated in your browsing language Automatically translated

Submission Method
Electronic via:
www.tenderarena.cz
Tenders may be submitted
Electronic submission: required
www.tenderarena.cz
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Place of performance
Award method
Dodací lhůta
Estimated value
6,000,000.00 CZK
Final contracted value
Not available
Award of contract
Not available
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.